Scientific Understanding of COVID-19: The First Step to Vanquishing the Current Pandemic.
作者信息
Shin Eui-Cheol
机构信息
Laboratory of Immunology and Infectious Diseases, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.
The Center for Epidemic Preparedness, KAIST, Daejeon 34141, Korea.
出版信息
Mol Cells. 2021 Jun 30;44(6):375-376. doi: 10.14348/molcells.2021.0146.
Abstract
摘要
相似文献
1
Scientific Understanding of COVID-19: The First Step to Vanquishing the Current Pandemic.对新冠病毒的科学认知：战胜当前疫情的第一步。
Mol Cells. 2021 Jun 30;44(6):375-376. doi: 10.14348/molcells.2021.0146.
2
COVID-19 vaccines: A race against time.新冠疫苗：与时间赛跑
Anaesth Crit Care Pain Med. 2021 Apr;40(2):100848. doi: 10.1016/j.accpm.2021.100848. Epub 2021 Mar 24.
3
Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed.实现全球公平分配 COVID-19 疫苗：需要加强国际伙伴关系，增强宣传和团结。
PLoS Med. 2021 Sep 13;18(9):e1003772. doi: 10.1371/journal.pmed.1003772. eCollection 2021 Sep.
4
Covid-19 eradication: stopping transmission between countries.新冠疫情根除：阻止国家间传播。
BMJ. 2021 Jun 7;373:n1425. doi: 10.1136/bmj.n1425.
5
Influenza Virus and SARS-CoV-2 Vaccines.流感病毒和 SARS-CoV-2 疫苗。
J Immunol. 2021 Jun 1;206(11):2509-2520. doi: 10.4049/jimmunol.2001287. Epub 2021 May 21.
6
Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.SARS-CoV-2/COVID-19 大流行管理的潜在治疗靶点和疫苗开发：近期进展综述。
Front Immunol. 2021 Jun 30;12:658519. doi: 10.3389/fimmu.2021.658519. eCollection 2021.
7
Viral targets for vaccines against COVID-19.针对 COVID-19 的疫苗的病毒靶点。
Nat Rev Immunol. 2021 Feb;21(2):73-82. doi: 10.1038/s41577-020-00480-0. Epub 2020 Dec 18.
8
Special focus 'SARS-CoV-2 / COVID-19: advances in developing vaccines and immunotherapeutics'.特别关注“SARS-CoV-2 / COVID-19：疫苗和免疫疗法研发进展”
Hum Vaccin Immunother. 2020 Dec 1;16(12):2888-2890. doi: 10.1080/21645515.2020.1847952.
9
Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges.利用 SARS-CoV-2 的基因组学和免疫病理学开发疫苗：前景与挑战。
Hum Vaccin Immunother. 2021 Mar 4;17(3):620-637. doi: 10.1080/21645515.2020.1812313. Epub 2020 Sep 16.
10
WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic.世界卫生组织批准中国科兴新冠疫苗对遏制疫情至关重要。
Nature. 2021 Jun;594(7862):161-162. doi: 10.1038/d41586-021-01497-8.
本文引用的文献
1
Experimental Models for SARS-CoV-2 Infection.SARS-CoV-2 感染的实验模型。
Mol Cells. 2021 Jun 30;44(6):377-383. doi: 10.14348/molcells.2021.0094.
2
Phenotypes and Functions of SARS-CoV-2-Reactive T Cells.SARS-CoV-2 反应性 T 细胞的表型和功能。
Mol Cells. 2021 Jun 30;44(6):401-407. doi: 10.14348/molcells.2021.0079.
3
An Impaired Inflammatory and Innate Immune Response in COVID-19.新型冠状病毒病中的炎症和先天免疫反应受损。
Mol Cells. 2021 Jun 30;44(6):384-391. doi: 10.14348/molcells.2021.0068.
4
Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis.体液免疫对 SARS-CoV-2 的作用及对 COVID-19 发病机制的影响。
Mol Cells. 2021 Jun 30;44(6):392-400. doi: 10.14348/molcells.2021.0075.
5
Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic Interventions.SARS-CoV-2 的分子视角：病理学、免疫逃逸和治疗干预。
Mol Cells. 2021 Jun 30;44(6):408-421. doi: 10.14348/molcells.2021.0026.
6
SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）突变、疫苗与免疫：关注变异株的影响
Signal Transduct Target Ther. 2021 May 22;6(1):203. doi: 10.1038/s41392-021-00623-2.
7
Vaccine development for emerging infectious diseases.新发传染病疫苗的研发。
Nat Med. 2021 Apr;27(4):591-600. doi: 10.1038/s41591-021-01301-0. Epub 2021 Apr 12.
8
SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals.COVID-19患者和未接触者中针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的T细胞反应
Immune Netw. 2021 Feb 17;21(1):e2. doi: 10.4110/in.2021.21.e2. eCollection 2021 Feb.
9
The first 12 months of COVID-19: a timeline of immunological insights.COVID-19 出现的头 12 个月：免疫学研究进展一览。
Nat Rev Immunol. 2021 Apr;21(4):245-256. doi: 10.1038/s41577-021-00522-1. Epub 2021 Mar 15.
Zotero 插件